SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 217 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $150,189 | -36.1% | 169,514 | +13.4% | 0.09% | -43.7% |
| Q3 2022 | $235,000 | +32.0% | 149,477 | +68.4% | 0.17% | +47.8% |
| Q2 2022 | $178,000 | -12.3% | 88,738 | +2.1% | 0.11% | -0.9% |
| Q1 2022 | $203,000 | -40.6% | 86,934 | +18.1% | 0.11% | -35.6% |
| Q4 2021 | $342,000 | +4.3% | 73,584 | +71.4% | 0.18% | -6.8% |
| Q3 2021 | $328,000 | -15.5% | 42,929 | +7.2% | 0.19% | -17.0% |
| Q2 2021 | $388,000 | +29.8% | 40,058 | +10.9% | 0.23% | +16.8% |
| Q1 2021 | $299,000 | +79.0% | 36,123 | +47.9% | 0.20% | +60.7% |
| Q4 2020 | $167,000 | -4.6% | 24,426 | +55.6% | 0.12% | -12.2% |
| Q3 2020 | $175,000 | +130.3% | 15,702 | +29.7% | 0.14% | +110.6% |
| Q2 2020 | $76,000 | +13.4% | 12,102 | -53.5% | 0.07% | +10.0% |
| Q1 2020 | $67,000 | -24.7% | 26,002 | +23.2% | 0.06% | -22.1% |
| Q4 2019 | $89,000 | – | 21,100 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |